{"id":488,"date":"2007-07-01T12:02:00","date_gmt":"2007-07-01T10:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/sunitinib-bei-fortgeschrittenen-gastrointestinalen-stromatumoren"},"modified":"2007-07-01T12:02:00","modified_gmt":"2007-07-01T10:02:00","slug":"sunitinib-bei-fortgeschrittenen-gastrointestinalen-stromatumoren","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/sunitinib-bei-fortgeschrittenen-gastrointestinalen-stromatumoren","title":{"rendered":"Sunitinib bei fortgeschrittenen gastrointestinalen Stromatumoren"},"content":{"rendered":"<p>Gastrointestinale Stromatumoren (GIST) sind seltene, vom Bindegewebe ausgehende, b\u00f6sartige Tumoren des Gastrointestinaltrakts (Inzidenz: 1-2 Neuerkrankungen\/100000 Einwohner). Mindestens die H\u00e4lfte der Patienten entwickelt Metastasen, meist in der Leber und\/oder Bauchh\u00f6hle. Die Tumorzellen exprimieren auf ihrer Oberfl\u00e4che spezifische Rezeptor-Tyrosinkinasen, wie z.B. den Stem Cell Factor Receptor (SCFR oder c-KIT, CD117) bzw. deutlich seltener den Platelet Derived Growth [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gastrointestinale Stromatumoren (GIST) sind seltene, vom Bindegewebe ausgehende, b\u00f6sartige Tumoren des Gastrointestinaltrakts (Inzidenz: 1-2 Neuerkrankungen\/100000 Einwohner). Mindestens die H\u00e4lfte der Patienten entwickelt Metastasen, meist in der Leber und\/oder Bauchh\u00f6hle. Die Tumorzellen exprimieren auf ihrer Oberfl\u00e4che spezifische Rezeptor-Tyrosinkinasen, wie z.B. den Stem Cell Factor Receptor (SCFR oder c-KIT, CD117) bzw. deutlich seltener den Platelet Derived Growth [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[937,938,936,803,802],"class_list":["post-488","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-gastrointestinale-stromatumoren","tag-gist","tag-sunitinib","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=488"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/488\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}